Pope Francis's popemobile set to become health clinic for Gaza children
Vatican City: One of
Pope Francis
's popemobiles is being transformed into a
mobile health clinic
for children in the Gaza Strip, fulfilling one of his final wishes, the Vatican's official media outlet said on Sunday.
The vehicle, used by the late pontiff during his 2014 visit to the Holy Land, is being outfitted with diagnostic and emergency medical equipment to help young patients in the Palestinian enclave, where health services have been devastated by the Israeli invasion.
Pope Francis, who died last month, entrusted the initiative to the Catholic aid organisation
Caritas Jerusalem
in the months before his death, Vatican News said.
"This is a concrete, life-saving intervention at a time when the health system in Gaza has almost completely collapsed," Peter Brune, Secretary General of Caritas Sweden, which is supporting the project, told Vatican News.
The mobile unit will be equipped with rapid infection tests, vaccines, diagnostic tools, and suture kits, and staffed by medical personnel. Caritas plans to deploy the clinic to communities without access to functioning healthcare facilities once humanitarian access to Gaza is feasible.
"It's not just a vehicle," Brune added. "It's a message that the world has not forgotten about the children in Gaza."
Gaza has a tiny Christian community and the Vatican has said Francis used to call the Holy Family Church in Gaza on an almost daily basis for much of the war, which started in October 2023 when Hamas militants attacked southern Israel.
Francis had a number of popemobiles, with the one used in the 2014 visit to Israel and the Palestinian Territories staying in the region following his return to the Vatican.
A conclave to elect a new pope starts on May 7.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
19 hours ago
- Time of India
Shibu regains consciousness after three days
1 2 R anchi: Former Jharkhand chief minister and JMM founding patron Shibu Soren regained consciousness in New Delhi's Gangaram Hospital after three days, his party said on Sunday. "Guru Ji (Shibu) regained his consciousness after three days. He is currently under observation at the ICU and his condition is stable. He was given food orally today. We are praying for his speedy recovery and hoping that he will soon return to Jharkhand," JMM general secretary Supriyo Bhattacharya said. While Shibu's son, CM Hemant Soren stayed put in New Delhi, prayer services were organised in the city on Sunday for his recovery. Members of the tribal community offered their prayers at the Sarna sthals in Siromtoli. Sarna Samiti chief priest Jaglal Pahan said, "We prayed for his speedy recovery along with the people of the state. People's prayers seem to have paid off, as his health condition has returned to normal. The collective prayers and well-wishes from people across the state may have contributed to his improved health." Christian community of the city also prayed for the former Union minister during Sunday mass and highlighted his contribution in separate statehood movement.
Time of India
a day ago
- Time of India
Gun, bombs - and now drugs? Israel reportedly sending food mixed with deadly narcotic to hungry Palestinians
In a shocking allegation that further deepens the humanitarian crisis in Gaza, Palestinian authorities claim that flour distributed through U.S.- and Israeli-backed aid centers contained oxycodone—a highly addictive opioid known to cause severe health complications and death. The Gaza government media office said the pills were discovered inside flour bags distributed by so-called 'American-Israeli' aid centers. Officials documented four testimonies from civilians who allegedly found the prescription drug mixed into the food supplies. Oxycodone, typically used for chronic pain relief, can be fatal if misused, especially in a community already devastated by war, hunger, and displacement. Gaza officials warned that some pills may have been ground or dissolved directly into the flour, raising fears of a deliberate act to poison the population and trigger mass addiction. Blaming Israel directly, the media office condemned what it called 'a heinous crime' designed to destroy Palestinian society from within. It accused Israeli authorities of exploiting the blockade to weaponize humanitarian aid, describing U.S.-Israeli aid centers as 'death traps.' The Gaza Humanitarian Foundation (GHF), a joint U.S.-Israeli aid group operating in the region, is at the center of the storm. Human rights organizations have denounced its lack of oversight and called for its immediate suspension. A coalition of 15 legal and human rights groups warned that its operations may constitute complicity in crimes under international law—including war crimes and genocide. Live Events Adding to the controversy, Israeli outlet Haaretz reported that IDF soldiers admitted to shooting unarmed Palestinians at aid collection points. Gaza's Health Ministry claims over 500 Palestinians have been killed near aid centers since late May. The International Criminal Court has issued arrest warrants for Israeli Prime Minister Benjamin Netanyahu and former Defense Minister Yoav Gallant for alleged war crimes in Gaza. Israel also faces a genocide case at the International Court of Justice. As starvation mounts in Gaza, the reports of drug-laced food have sparked international outrage and renewed calls for independent humanitarian oversight in the region.
Hans India
a day ago
- Hans India
Deadly blood cancer can now be detected early with blood test: Study
A team of Israeli and American scientists have developed a groundbreaking blood test that may soon revolutionize the early detection of leukaemia and other blood-related disorders. The test, which analyzes a simple blood sample, could eliminate the need for invasive bone marrow biopsies currently used in diagnosis. Published in the prestigious journal Nature Medicine, the study was led by researchers from the Weizmann Institute of Science in Israel. The team focused their work on identifying early indicators of myelodysplastic syndrome (MDS), an age-related condition in which blood-forming stem cells fail to develop correctly. MDS is particularly dangerous as it can lead to severe anaemia and progress into acute myeloid leukaemia (AML), a fast-growing type of blood cancer prevalent among adults. Currently, diagnosing MDS requires a painful and intrusive procedure — bone marrow sampling — which involves drilling into the pelvic bone under local anaesthesia. For many patients, especially older adults, this process is uncomfortable and distressing. The new research offers a promising alternative. The scientists discovered that rare blood-forming stem cells, which occasionally escape from the bone marrow and circulate in the bloodstream, carry crucial genetic clues about the early development of MDS. Using advanced single-cell genetic sequencing techniques, the researchers successfully decoded the information contained within these rare cells — all from a routine blood draw. One of the most remarkable findings was that these circulating stem cells not only provide early markers of disease but also appear to act as biological 'clocks' that reflect a person's chronological aging. 'These stem cells give us insights not only into early-stage disease but also into how aging progresses differently in men and women,' explained Dr. Nili Furer of the Weizmann Institute. 'We found that in males, the changes in these cells occur earlier than in females, potentially explaining the higher incidence of blood cancers among men.' The study holds significant promise for the future of cancer diagnostics. By replacing an uncomfortable and invasive procedure with a simple blood test, early detection becomes more accessible and patient-friendly. Furthermore, the researchers believe this breakthrough method could be adapted to detect other age-related blood disorders beyond MDS and AML. A large-scale international clinical trial is already underway to validate the effectiveness of the blood test across multiple medical centers worldwide. If successful, this new method could pave the way for more accurate, less invasive, and earlier diagnoses of life-threatening blood cancers, ultimately improving outcomes and quality of life for countless patients.
